Navigation Links
Reportlinker Adds World Influenza Vaccines Market 2011-2021
Date:4/5/2011

against H5N1 Virus (Avian Flu)

8.1.6 Pandemic Preparedness: Vaccine against H1N1 Virus (Swine Flu)

8.2 Novartis

8.2.1 Acquisition of Chiron - Optaflu Cell-Based Vaccine

8.2.2 Investigational Pre-Pandemic Vaccine AFLUNOV

8.2.3 Alliance with Intercell AG - Use of Next-Generation IC31 Adjuvant

8.2.4 Fluad MF59 Adjuvanted Influenza Vaccine More Efficacious than Non-Adjuvanted Influenza Vaccines in Children

8.2.5 Commitment to Pandemic Preparedness

8.2.6 FDA Approves Agriflu

8.3 GlaxoSmithKline PLC

8.3.1 Stockpile Initiative

8.3.2 Prepandrix - The H5N1 Prepandemic Vaccine

8.3.3 Late Phase Studies on New Generation Seasonal Influenza Vaccine

8.4 Other Vaccines in the Pipeline

8.5 Ongoing Studies on Vaccine Development

8.5.1 Universal Influenza Vaccine

8.5.2 Development of Novel Vaccine Delivery Systems 

8.5.3 Pandemic Vaccine

8.5.4 Global Pandemic Influenza Action Plan (GAP) by the WHO

8.5.4.1 New Production Facilities

8.5.4.2 GAP Initiatives to Fund Influenza R&D

8.5.4.3 Constraints Faced by Research and Development

8.5.4.4 Steps Taken to Overcome Constraints

8.5.4.5 An Example of Technology Transfer in India 

9. Experts' Views on Influenza Vaccines 

9.1 Interview with Richard de Souza, CEO, Archimedes Pharma, and Dr Alan Smith, VP, R&D, Archimedes Development Limited 

9.1.1 On the Constraints of Developing a Seasonal Influenza Vaccine

9.1.2 On the Principal Drivers and Restraints in the Influenza Vaccine Market 

9.1.3 On Vaccination Coverage Rates in the Mature and Emerging Markets

9.1.4 On Important Pipeline Developments 

9.1.5 On Vaccine Development in the Emerging Markets 

9.1.6 On the Future of Influenza Vaccines 

9.2 Interview with Catherine Ammon, World Heath Organization, Switzerland

9.2.
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Reportlinker Adds Drug Delivery in Cancer - technologies, markets and companies
2. Reportlinker Adds Enzymes in Drug Manufacturing
3. Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects
4. Reportlinker Adds Pain Therapeutics - Drugs, Markets and Companies
5. Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing
6. Reportlinker Adds Top 500 Pharmaceuticals Industry Report (Global)
7. Reportlinker Adds Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market
8. Reportlinker Adds Top 200 Biopharmaceuticals Industry Report (Global)
9. Reportlinker Adds Butadiene Market In Americas To 2020 - Recovery In End Use Markets Providing Positive Demand Growth In The Region
10. Reportlinker Adds Medical Imaging Markets
11. Reportlinker Adds Cardiac Marker Diagnostic Testing Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 Braeburn Pharmaceuticals announced today ... focus beyond addiction and pain to include ... has acquired an implantable, six-month formulation of ... treatment of schizophrenia from Endo Pharmaceuticals. With ... to other potential applications of the implant ...
(Date:5/1/2015)... May 1, 2015 Pharmacyclics, Inc. (the "Company") ... the quarter ended March 31, 2015, as well as ... Inc., no conference call will be held. ... ended March 31, 2015 increased to $206 million from ... , Worldwide IMBRUVICA ® (ibrutinib) net product ...
(Date:5/1/2015)... May 1, 2015  Misonix, Inc. (NASDAQ: ... designs, manufactures and markets innovative therapeutic ultrasonic products ... cosmetic surgery, laparoscopic surgery and other surgical applications, ... for the third quarter fiscal year 2015 on ... a conference call that same day, Thursday, May ...
Breaking Medicine Technology:Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 33
... Oct. 16 Solos Endoscopy, Inc. (Pink Sheets: SNDY) ... received multiple purchase orders for its MammoView(TM) line ... Wheaton Franciscan Healthcare is one of the largest ... Endoscopy,s MammoView(TM) system employs advanced micro endoscopes and ...
... each state is responsible for its Women Infant Children program ... supplies. A state bid notification for breastpumps and supplies was ... needs further attention. The bid,s breastpump requirement was that the ... The state felt that it was acceptable for the pumps ...
Cached Medicine Technology:Solos Endoscopy, Inc. Receives Multiple Purchase Orders for its MammoView(TM) Product Line 2Do Women Have a Right to a Breastpump That Works? Asks Hygeia 2
(Date:5/3/2015)... Francisco, CA (PRWEB) May 03, 2015 ... (CFHI), announced it will be awarding the 2015 ... Jennifer Knight and Selemawit Ghebrendrias, are the deserving recipients ... champion for global service, Harris Llewellyn Wofford. The two ... service and passion for global health. , CFHI ...
(Date:5/3/2015)... Missouri (PRWEB) May 03, 2015 ... business that will directly impact your career? The ... designed for dynamic leaders in multinational companies and ... company. In a changing global landscape, differences in ... and relationships. The EMIB program develops the global ...
(Date:5/3/2015)... HealthPostures, a pioneering ergonomics company ... appearance at the , May 5 - 7, 2015 ... exhibit at the conference include its bestselling TaskMate sit ... is the 6100 TaskMate Executive. Features of the 6100 ... keyboard tray, extended platform work surface and supply holders. ...
(Date:5/2/2015)... 2015 “ ActOn ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... with organizations to make a difference. , In this material ... things that aren’t about money, which is why those things ...
(Date:5/2/2015)... “ Peachtree Audio ” was featured ... which features the latest and coolest technology products available ... reporter for NewsWatch, conducted the review and shared with ... , Music is an important part of people’s lives ... given the royal treatment. Peachtree Audio does just that ...
Breaking Medicine News(10 mins):Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 2Health News:SF-based Global Health Non-Profit Awards Harris Wofford Global Service Fellowship 3Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2
... same period in Fiscal 2008 -, ... otherwise noted),BELLEVILLE, ON, May 6 /PRNewswire-FirstCall/ - Bioniche ... Canadian biopharmaceutical company, today announced financial results for ... ending March 31, 2009. , "The year-to-date revenue ...
... (NYSE: GSK ) today announced that it has ... Wellbutrin XL (R) in the United States ... (NYSE, TSX: BVF), for $510 million (euro 340 million). ... United States.Generic competition to Wellbutrin XL began at ...
... Outside of Houston PHOENIX, May 6 Today ... D. Anderson Cancer Center announced they will create the M. ... leading provider of health care and the nation,s leading cancer ... level of cancer care in Arizona.Located at US 60 and ...
... for generous contribution to New York University College of Dentistry ... ... D.D.S. and his wife, Ellen Linhart, have established the New York ... Linhart’s alma mater. In honor of this act of philanthropy, New ...
... Max Muscle Sports Nutrition,s newest product innovation is L-Tox, for advanced ... along with protective and regenerative factors. , ... Anaheim, ... Administration (FDA) www.fda.gov issued a stop product use directive ...
... to the transition from in-patient to outpatient care for diabetes patients ... discussion on the Diabetes Best Practices Website provide up-to-date information and ... ... 6, 2009 -- "Diabetes Discharge planning is a national priority," says ...
Cached Medicine News:Health News:Bioniche Reports Fiscal 2009 Third Quarter 2Health News:Bioniche Reports Fiscal 2009 Third Quarter 3Health News:Bioniche Reports Fiscal 2009 Third Quarter 4Health News:Bioniche Reports Fiscal 2009 Third Quarter 5Health News:Bioniche Reports Fiscal 2009 Third Quarter 6Health News:Bioniche Reports Fiscal 2009 Third Quarter 7Health News:Bioniche Reports Fiscal 2009 Third Quarter 8Health News:Bioniche Reports Fiscal 2009 Third Quarter 9Health News:Bioniche Reports Fiscal 2009 Third Quarter 10Health News:GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million 2Health News:Banner Health, M. D. Anderson Announce Cancer Care Facility for Arizona 2Health News:Banner Health, M. D. Anderson Announce Cancer Care Facility for Arizona 3Health News:Manhattan Dentist Inducted Into The Sir Harold Acton Society 2Health News:Max Muscle Sports Nutrition Offers Support for Hydroxycut Recall 2Health News:Max Muscle Sports Nutrition Offers Support for Hydroxycut Recall 3Health News:Diabetes Discharge Planning is this the latest Topic in Focus at the Diabetes Best Practices Website 2
Liquichek™ Homocysteine Control is a liquid control for monitoring homocysteine test procedures. This product can be used or methods such as HPLC and automated immunoassay procedures....
Bio-Rad's Liquichek™ D-dimer Control provides the laboratory with a liquid, trilevel, human plasma based control for the monitoring of D-dimer testing on most automated coagulation, chemistry a...
Lyphochek Diabetes Control is a human whole blood based product used to monitor hemoglobin fractions associated with diabetes, including Hemoglobins A1, A1C, F and Total Glycated Hemoglobin....
Lyphochek Hemoglobin A2 Control is a human whole blood based product designed to monitor the performance of automated and manual procedures for the measurement of hemoglobin variants, including Hemog...
Medicine Products: